Log In
BCIQ
Print this Print this
 

Perenan, ergoloid mesylates

  Manage Alerts
Collapse Summary General Information
Company Sanofi
DescriptionDihydrogenated ergot derivative alkaloid
Molecular Target Adrenergic receptor alpha 2a (ADRA2A)
Mechanism of ActionAdrenergic receptor alpha 2 (ADRA2) antagonist
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today